Revenue of the cold & cough remedies market worldwide by country 2022

From the selected regions, the ranking by revenue in the cold & cough remedies segment of the OTC pharmaceuticals market is led by the United States with 10.2 billion U.S. dollars and is followed by China (9 billion U.S. dollars). In contrast, the ranking is trailed by Saudi Arabia with 111.53 million U.S. dollars, recording a difference of 10.1 billion U.S. dollars to the United States.

Find other insights concerning similiar markets and segments, such as a ranking of subsegments in Europe regarding revenue in the OTC Pharmaceuticals market as a whole and a ranking by country regarding revenue in the OTC pharmaceuticals market.

Revenue of the cold & cough remedies market worldwide by country in 2022 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

The cold and cough segment comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Citation formats